In bladder and upper tract urothelial carcinomas (UTUC), KMT2C co-occurred with genes such as SPTA1 and LRP1B, suggesting a hypermutated, immunoresponsive phenotype. This evidence concerns the gene SPTA1 and renal pelvis/ureter urothelial carcinoma.